ClassID:

94519

C07D239/86 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems; Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4

Sub-classes:
Recent Application in this class:
#1
20260001851
2026-01-01

TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL APPLICATION THEREOF

#2
20230348460
2023-11-02

ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS

#3
20230339960
2023-10-26

Bicyclic-fused heteroaryl or aryl compounds

#4
20230043449
2023-02-09

TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL APPLICATION THEREOF

#5
20210276988
2021-09-09

4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections

#6
20200377511
2020-12-03

Bicyclic-fused heteroaryl or aryl compounds

#7
20200216469
2020-07-09

Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies

#8
20190345157
2019-11-14

Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds

#9
20190270751
2019-09-05

Bicyclic-fused heteroaryl or aryl compounds

#10
20180319818
2018-11-08

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#11
20180312527
2018-11-01

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#12
20180312526
2018-11-01

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#13
20180127432
2018-05-10

Bicyclic-fused heteroaryl or aryl compounds

#14
20170333433
2017-11-23

Quinazoline derivatives substituted by aniline, preparation method and use thereof

#15
20170304305
2017-10-26

QUINAZOLINE DERIVATIVES SUBSTITUTED BY ANILINE, PREPARATION METHOD AND USE THEREOF

#16
20170210759
2017-07-27

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#17
20170190672
2017-07-06

Methods for preparation of quinazoline derivatives

#18
20160347760
2016-12-01

Bicyclic-fused heteroaryl or aryl compounds

#19
20160257673
2016-09-08

4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections

#20
20150344458
2015-12-03

Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yi)prop-2-en-1-one

#21
20150284405
2015-10-08

Bicyclic-fused heteroaryl or aryl compounds

#22
20150191474
2015-07-09

Fused heterocyclic compound

#23
20150086545
2015-03-26

COMBINATION THERAPY OF HER EXPRESSING TUMORS

#24
20130336887
2013-12-19

Compounds and methods for enzyme-mediated tumor imaging and therapy

#25
20130184297
2013-07-18

Quinazoline derivatives substituted by aniline, preparation method and use thereof

#26
20130012489
2013-01-10

Morpholinylquinazolines

#27
20120251530
2012-10-04

COMBINATION THERAPY OF HER EXPRESSING TUMORS

#28
20110237601
2011-09-29

Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists

#29
20110071148
2011-03-24

COMPOUNDS AS THE ESTROGEN RELATED RECEPTORS MODULATORS AND THE USES THEREOF

#30
20100261740
2010-10-14

4-(tetrazol-5-yl)-quinazoline derivatives as anti-cancer agent

#31
20100125139
2010-05-20

PROCESS FOR PREPARING QUINAZOLINE RHO-KINASE INHIBITORS AND INTERMEDIATES THEREOF

#32
20090324495
2009-12-31

Compounds and methods for enzyme-mediated tumor imaging and therapy

#33
20090312322
2009-12-17

Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3

#34
20090285782
2009-11-19

4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections

#35
20090226377
2009-09-10

Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors

#36
20070100031
2007-05-03

Ultraviolet light absorbers

#37
20070020261
2007-01-25

Combination therapy of her expressing tumors

#38
20060172994
2006-08-03

Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists

#39
20050070559
2005-03-31

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3